\-\ Texto\\:\\ \ \(0\)\
\-\ normal\ \(4026\)\
\-\ mr\\ images\\ shows\\ multiple\\ masses\\ in\\ the\\ periphery\\ of\\ both\\ cerebellar\\ hemispheres\\,\\ in\\ the\\ \\ fourth\\ \\ ventricle\\ and\\ along\\ the\\ pial\\ surface\\ of\\ the\\ spinal\\ cord\\ \\.\ \(0\)\
\-\ disseminated\\ medulloblastoma\ \(1\)\
\-\ the\\ differential\\ diagnosis\\ of\\ csf\\ disseminated\\ tumors\\ includes\\:\ \(0\)\
\-\ \\â\\€\\¢\\ medulloblastoma\ \(1\)\
\-\ \\â\\€\\¢\\ other\\ primitive\\ neuroectodermal\\ tumor\\ \\(pnet\\)\ \(0\)\
\-\ \\â\\€\\¢\\ germ\\ cell\\ \\(pineal\\ region\\)\\ tumors\ \(1\)\
\-\ \\â\\€\\¢\\ ependymoma\ \(8\)\
\-\ six\\ year\\ old\\ boy\\ with\\ vomiting\ \(0\)\
\-\ medulloblastomas\\ are\\ malignant\\ primitive\\ neuroectodermal\\ tumors\\ involving\\ the\\ cerebellum\\,\\ and\\ are\\ the\\ most\\ common\\ type\\ of\\ neoplasm\\ to\\ disseminate\\ along\\ the\\ csf\\ pathways\\.\ \(0\)\
\-\ at\\ least\\ one\\ report\\ indicated\\ that\\ contrast\\-enhanced\\ mr\\ imaging\\ is\\ more\\ sensitive\\ \\(83\\%\\)\\ than\\ csf\\ cytologic\\ analysis\\ \\(60\\%\\â\\€\\“78\\%\\)\\ in\\ establishing\\ the\\ presence\\ of\\ csf\\ dissemination\\,\\ even\\ when\\ multiple\\ csf\\ samples\\ were\\ obtained\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ csf\\:\\ 0\\.13517024059871258\ \(0\)\
\-\ neuroectodermal\\:\\ 0\\.09155954093525329\ \(0\)\
\-\ primitive\\:\\ 0\\.08420336190825782\ \(0\)\
\-\ disseminated\\:\\ 0\\.07885758350488294\ \(0\)\
\-\ medulloblastoma\\:\\ 0\\.07523289124630969\ \(0\)\
\-\ tumors\\:\\ 0\\.07294809903796594\ \(0\)\
\-\ \\â\\€\\“78\\:\\ 0\\.06678423048459468\ \(0\)\
\-\ medulloblastomas\\:\\ 0\\.05846141011589688\ \(0\)\
\-\ disseminate\\:\\ 0\\.05846141011589688\ \(0\)\
\-\ establishing\\:\\ 0\\.05459151902676059\ \(0\)\
\-\ pathways\\:\\ 0\\.05321029511165487\ \(0\)\
\-\ cytologic\\:\\ 0\\.05204248693114534\ \(0\)\
\-\ samples\\:\\ 0\\.05204248693114534\ \(0\)\
\-\ pial\\:\\ 0\\.05013858974719908\ \(0\)\
\-\ dissemination\\:\\ 0\\.04934040402251858\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.047485283381693576\ \(0\)\
\-\ \\%\\:\\ 0\\.04530275075786381\ \(0\)\
\-\ along\\:\\ 0\\.04278869510391691\ \(0\)\
\-\ mr\\:\\ 0\\.04113938593858234\ \(0\)\
\-\ pineal\\:\\ 0\\.04052865546338463\ \(0\)\
\-\ 83\\:\\ 0\\.03942879175244147\ \(0\)\
\-\ pnet\\:\\ 0\\.03922675957757661\ \(0\)\
\-\ contrast\\-enhanced\\:\\ 0\\.03628914191841931\ \(0\)\
\-\ periphery\\:\\ 0\\.03615505421312082\ \(0\)\
\-\ sensitive\\:\\ 0\\.03516008450053682\ \(0\)\
\-\ hemispheres\\:\\ 0\\.03449120111306957\ \(0\)\
\-\ germ\\:\\ 0\\.03349294900980348\ \(0\)\
\-\ analysis\\:\\ 0\\.03295159322205996\ \(0\)\
\-\ least\\:\\ 0\\.03244635553646395\ \(0\)\
\-\ cerebellum\\:\\ 0\\.03220583509468684\ \(0\)\
\-\ six\\:\\ 0\\.03182119626610029\ \(0\)\
\-\ fourth\\:\\ 0\\.03131353937001726\ \(0\)\
\-\ ependymoma\\:\\ 0\\.028977923008998197\ \(0\)\
\-\ report\\:\\ 0\\.028977923008998197\ \(0\)\
\-\ even\\:\\ 0\\.028824872195986687\ \(0\)\
\-\ surface\\:\\ 0\\.028576464447327664\ \(0\)\
\-\ 60\\:\\ 0\\.028241834005561472\ \(0\)\
\-\ indicated\\:\\ 0\\.028011550087498057\ \(0\)\
\-\ cerebellar\\:\\ 0\\.027921361432147157\ \(0\)\
\-\ multiple\\:\\ 0\\.027269787931504075\ \(0\)\
\-\ includes\\:\\ 0\\.026097578756354815\ \(0\)\
\-\ vomiting\\:\\ 0\\.024716354841249094\ \(0\)\
\-\ cord\\:\\ 0\\.024599802425798494\ \(0\)\
\-\ ventricle\\:\\ 0\\.024260532708927484\ \(0\)\
\-\ presence\\:\\ 0\\.023498375897402494\ \(0\)\
\-\ malignant\\:\\ 0\\.023399020275600767\ \(0\)\
\-\ spinal\\:\\ 0\\.023180122805905954\ \(0\)\
\-\ obtained\\:\\ 0\\.023014137126847287\ \(0\)\
\-\ involving\\:\\ 0\\.0227152065454795\ \(0\)\
\-\ neoplasm\\:\\ 0\\.022046640726605518\ \(0\)\
\-\ boy\\:\\ 0\\.022005468029742205\ \(0\)\
\-\ \\(\\:\\ 0\\.021889749280116985\ \(0\)\
\-\ masses\\:\\ 0\\.0218832757423946\ \(0\)\
\-\ type\\:\\ 0\\.021822910820809928\ \(0\)\
\-\ \\)\\:\\ 0\\.02162235430646379\ \(0\)\
\-\ differential\\:\\ 0\\.020552725979946437\ \(0\)\
\-\ when\\:\\ 0\\.01854038816375762\ \(0\)\
\-\ region\\:\\ 0\\.018284857782116005\ \(0\)\
\-\ shows\\:\\ 0\\.017798285604006658\ \(0\)\
\-\ are\\:\\ 0\\.01764960412923639\ \(0\)\
\-\ one\\:\\ 0\\.017543419570535183\ \(0\)\
\-\ cell\\:\\ 0\\.017486672057435503\ \(0\)\
\-\ than\\:\\ 0\\.01696249132513844\ \(0\)\
\-\ common\\:\\ 0\\.01694141827239695\ \(0\)\
\-\ both\\:\\ 0\\.016531818111258496\ \(0\)\
\-\ more\\:\\ 0\\.01619072961600126\ \(0\)\
\-\ imaging\\:\\ 0\\.015167225942845475\ \(0\)\
\-\ tumor\\:\\ 0\\.015092668951597055\ \(0\)\
\-\ most\\:\\ 0\\.014945720770667243\ \(0\)\
\-\ other\\:\\ 0\\.014921504156836731\ \(0\)\
\-\ diagnosis\\:\\ 0\\.014865297960457727\ \(0\)\
\-\ were\\:\\ 0\\.014699138914317586\ \(0\)\
\-\ images\\:\\ 0\\.012418665848101168\ \(0\)\
\-\ that\\:\\ 0\\.011181672186051692\ \(0\)\
\-\ normal\\:\\ 0\\.01014857920150834\ \(0\)\
\-\ in\\:\\ 0\\.009577209775914886\ \(0\)\
\-\ the\\:\\ 0\\.009426087593429031\ \(0\)\
\-\ at\\:\\ 0\\.00877093297599722\ \(0\)\
\-\ \\:\\:\\ 0\\.008562687999929281\ \(0\)\
\-\ year\\:\\ 0\\.007243221736916021\ \(0\)\
\-\ old\\:\\ 0\\.006628292400471626\ \(0\)\
\-\ \\,\\:\\ 0\\.006152501489029258\ \(0\)\
\-\ of\\:\\ 0\\.004413022757499562\ \(0\)\
\-\ is\\:\\ 0\\.004259778624126709\ \(0\)\
\-\ to\\:\\ 0\\.0032353644579014114\ \(0\)\
\-\ and\\:\\ 0\\.0027274091777608855\ \(0\)\
\-\ with\\:\\ 0\\.0008863952734082556\ \(0\)\
\-\ \\.\\:\\ 0\\.0008068076385760517\ \(0\)\
